Related Experiment Videos
[Treatment of acute myocardial infarct with magnesium]
1Interné oddelenie A, NsP Zilina.
Insights
Magnesium (Mg) infusion significantly reduced heart failure, arrhythmias, and mortality in acute myocardial infarction patients. This study highlights Mg's protective role in managing heart attack complications.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Acute myocardial infarction (IM) is a leading cause of mortality worldwide.
- Management of IM complications remains a critical clinical challenge.
- Magnesium (Mg) has been investigated for its potential cardioprotective effects.
Purpose of the Study:
- To evaluate the efficacy of continuous magnesium (Mg) infusions in reducing adverse outcomes in patients with acute myocardial infarction (IM).
Main Methods:
- A randomized controlled trial involving 78 patients with acute IM.
- 44 patients received Mg infusions (50 mmol/24h then 12 mmol/24h) for 48 hours.
- 34 patients received a placebo; groups were comparable for risk factors and baseline characteristics.
Main Results:
- The Mg group showed a 22% lower incidence of heart failure.
- Arrhythmia incidence was 28% lower in the Mg group.
- In-hospital mortality was reduced by 22% in the Mg group.
Conclusions:
- Continuous magnesium (Mg) administration is associated with significant reductions in heart failure, arrhythmias, and mortality in acute myocardial infarction (IM) patients.
- Mg may play a crucial role in the acute management of myocardial infarction.
- Further research into the mechanisms of Mg's protective action is warranted.
Abstract:
The author examined 78 patients with acute myocardial infarction (IM). Forty-four patients were treated with magnesium (Mg) in continual 48 hours infusions, whereby during the first 24 hours the patients were given 50 mmol Mg, during the subsequent 24 hours 12 mmol Mg. Thirty-four patients with acute IM served as placebo group. The two groups did not differ statistically as regards the presence of risk factors (hypertension, hyperlipoproteinaemia, smoking), the incidence of diabetes (DM), age, sex the presence of Q and non Q IM. The two groups did not differ as regards the frequence of streptokinase administration. During the 21-day follow-up period (period in hospital) the authors recorded the following results: 1. In the Mg group the incidence of heart failure was by 22% lower. 2. In the Mg group the incidence of arrhythmias was by 28% lower. 3. In the Mg group the mortality rate in hospital was by 22% lower. In the discussion the author deals with the mechanism of the protective action of Mg in acute myocardial infarction and gives serum Mg concentration recorded during Mg administration.